Experimental epidemiologic study on the prevention of maternal-infant hepatitis B virus vertical transmission by immuno-prophylaxis
Yao Hon, Liu Pin, Chen Hong-pin
Abstract
Yao Hon, Liu Pin, Chen Hong-pin
Abstract
Objective To observe the effect of the application of hepatitis B vaccine and hepatitis B immune globulin for blocking the maternal-infant infection,and compare the blocking effect of different methods,so as to find out the best way for hepatitis B immuno-prophylaxis.Methods Experimental epidemiologic method was used to screen the pregnant women infected with hepatitis B virus.The infants whose mothers with infected hepatitis B virus were randomly divided into 2 groups,hepatitis B vaccine and hepatitis B specific immune globulin were used in one group,while the other group,only hepatitis B vaccine was used.In both groups of pregnant women,there were some individuals using hepatitis B specific immune globulin in the late pregnancy.In the 0-,1-and 2-year groups,hepatitis B virus-related markers were detected.In the 3 year-group,HBV-DNA was detected for the infants whose hepatitis B virus-related markers were positive at the age of 2 years.Results 128 cases of children completed the experiment,hepatitis B antibody positive conversion rate was 97%,infection rate was 3.1%.The children,whose mother used hepatitis B specific immune globulin in the late pregnancy,the infection rate was 3.57%.However,the children whose mother did not receive hepatitis B specific immune globulin in the late pregnancy,the infection rate was 3%.The infection rate of the group of infants,who only received hepatitis B vaccine,was 4.23%.Besides,the infection rate of the group of infants using hepatitis B vaccine and hepatitis B immune specific globulin was 1.75%.Conclusions The effect of the present hepatitis B vaccination program for blocking maternal-infant transmission of hepatitis B in our country is significant.But the blocking effectiveness for the pregnant women is not significant.Therefore,the use of hepatitis B immune specific globulin may not be necessary for the pregnant women.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of the application of hepatitis B vaccine and hepatitis B immune globulin for blocking the maternal-infant infection,and compare the blocking effect of different methods,so as to find out the best way for hepatitis B immuno-prophylaxis.Methods Experimental epidemiologic method was used to screen the pregnant women infected with hepatitis B virus.The infants whose mothers with infected hepatitis B virus were randomly divided into 2 groups,hepatitis B vaccine and hepatitis B specific immune globulin were used in one group,while the other group,only hepatitis B vaccine was used.In both groups of pregnant women,there were some individuals using hepatitis B specific immune globulin in the late pregnancy.In the 0-,1-and 2-year groups,hepatitis B virus-related markers were detected.In the 3 year-group,HBV-DNA was detected for the infants whose hepatitis B virus-related markers were positive at the age of 2 years.Results 128 cases of children completed the experiment,hepatitis B antibody positive conversion rate was 97%,infection rate was 3.1%.The children,whose mother used hepatitis B specific immune globulin in the late pregnancy,the infection rate was 3.57%.However,the children whose mother did not receive hepatitis B specific immune globulin in the late pregnancy,the infection rate was 3%.The infection rate of the group of infants,who only received hepatitis B vaccine,was 4.23%.Besides,the infection rate of the group of infants using hepatitis B vaccine and hepatitis B immune specific globulin was 1.75%.Conclusions The effect of the present hepatitis B vaccination program for blocking maternal-infant transmission of hepatitis B in our country is significant.But the blocking effectiveness for the pregnant women is not significant.Therefore,the use of hepatitis B immune specific globulin may not be necessary for the pregnant women.
Key concepts: Hepatitis B immune globulin, Medicine, Hepatitis B virus, Hepatitis B, Hepatitis B vaccine, Hepatitis, Immunology, Hepatitis A